Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision entry v3.6.5 was added to the record history, replacing v3.6.4. This reflects a minor update to the page's revision metadata rather than substantive study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now shows the latest revision, updating from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed. This reflects an update to the record's version in the history log.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a platform update. There is no visible impact on the study history entries or data.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating termination due to low enrollment. The study record version updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check77 days agoChange DetectedA new revision tag v3.5.5 is added to the page history, replacing v3.5.4, indicating an update to the record.SummaryDifference0.1%

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.